For the second time in three months, Pfizer has avoided a bellwether trial over claims that its smoking cessation drug, Chantix, causes suicidal thoughts.
Pfizer Resolves Another Chantix Case, Avoids Second Bellwether Trial
The Litigation Daily
January 17, 2013
This article requires premium access
This article requires premium access to The AmLaw Litigation Daily. Please sign in or subscribe to read the full text.